Prellis Biologics

Berkeley, CA · Founded 2016 · Privately Held (backing)

Developer of a bioprinting technology designed to recreate and engineer human tissues in vitro. Prellis Biologics is based in Berkeley, CA and was founded in 2016. It was valued at $110 million at its later-stage round in Nov 2023, the last priced event on record. It has raised $70.2 million across 5 recorded rounds; the latest was a $17 million early-stage round in Jun 2022.

PMV mark · valuation
$110.1M
Oct 2026
Priced at
its later-stage round
Nov 2023
Total raised
$70.2M
Last round
Early Stage VC
Jun 2022

Who backs Prellis Biologics?

16 investors
InvestorType
Plug and Play Tech Center—
SOSVVenture capital
Khosla VenturesVenture capital
IndieBioOther
True VenturesVenture capital
Congruent VenturesVenture capital
Celesta CapitalVenture capital
Future Ventures (San Francisco)Venture capital
Open Field CapitalVenture capital
Avidity PartnersAsset manager
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Prellis Biologics investors

16 investors are on record for Prellis Biologics, including Plug and Play Tech Center, SOSV, Khosla Ventures and IndieBio. By type, the record holds 8 venture capital firms and 1 asset manager. The early-stage round in Jun 2022 drew 19 investors.

Free account
More of Prellis Biologics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Prellis Biologics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Prellis Biologics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View